Pfizer
PFE
1,742 hedge funds and large institutions have $133B invested in Pfizer in 2014 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 750 increasing their positions, 716 reducing their positions, and 60 closing their positions.
39% more call options, than puts
Call options by funds: $1.91B | Put options by funds: $1.38B
15% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 60
5% more repeat investments, than reductions
Existing positions increased: 750 | Existing positions reduced: 716
0% less funds holding
Funds holding: 1,746 → 1,742 (-4)
0% less capital invested
Capital invested by funds: $133B → $133B (-$559M)
0.91% less ownership
Funds ownership: 73.97% → 73.06% (-0.91%)
3% less funds holding in top 10
Funds holding in top 10: 198 → 193 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$258M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$199M |
| 3 |
State Street
Boston,
Massachusetts
|
+$182M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$178M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$173M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$1.53B |
| 2 |
Renaissance Technologies
New York
|
-$286M |
| 3 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$203M |
| 4 |
MCM
Mason Capital Management
New York
|
-$199M |
| 5 |
IC
Institutional Capital
Chicago,
Illinois
|
-$185M |
PFE Hedge Fund Activity: Q3 2014 in Review
1,742 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2014, worth a combined $133B — down 0.42% from $133B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new PFE positions and 60 closed out — a net gain of 9 holders — while 750 added to existing stakes and 716 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $258M. The largest seller was Norges Bank, cutting an estimated $1.53B.
- 1,742 institutional investors held Pfizer (PFE) as of Q3 2014, down from 1,746 in Q2 2014.
- Funds reported $133B of Pfizer stock for Q3 2014, down 0.42% quarter-over-quarter.
- 69 funds opened new Pfizer positions in Q3 2014 and 60 closed out, a net change of +9 holders.
- The largest Pfizer buyer in Q3 2014 was D.E. Shaw & Co, an estimated $258M added.
- The largest Pfizer seller in Q3 2014 was Norges Bank, an estimated $1.53B sold.
Based on aggregated 13F filings for Q3 2014.